NCIt definition : An orally active, small molecule inhibitor of hypoxia inducible factor (HIF)-2alpha
(HIF-2a), with potential antineoplastic activity. Upon oral administration, belzutifan
binds to and blocks the function of HIF-2alpha, thereby preventing HIF-2alpha heterodimerization
and its subsequent binding to DNA. This results in decreased transcription and expression
of HIF-2alpha downstream target genes, many of which regulate hypoxic signaling. This
inhibits cell growth and survival of HIF-2alpha-expressing tumor cells. HIF-2alpha,
the alpha subunit for the heterodimeric transcription factor HIF-2, is overexpressed
in many cancers and promotes tumorigenesis.;
UNII : 7K28NB895L;
InChIKey : LOMMPXLFBTZENJ-ZACQAIPSSA-N;
CAS number : 1672668-24-4;
Drug name : Welireg;
Molecule name : PT 2977; MK-6482; MK 6482; PT-2977;